Azelastine

Generic Name
Azelastine
Brand Names
Astelin, Astepro, Astepro Allergy, Dymista
Drug Type
Small Molecule
Chemical Formula
C22H24ClN3O
CAS Number
58581-89-8
Unique Ingredient Identifier
ZQI909440X
Background

Azelastine, a phthalazine derivative, is an antihistamine available as an intranasal spray for the treatment of allergic and vasomotor rhinitis and as an ophthalmic solution for the treatment of allergic conjunctivitis. It is a racemic mixture, though there is no noted difference in pharmacologic activity between enantiomers, and was first granted FDA approv...

Indication

Intranasal azelastine is indicated for the symptomatic treatment of seasonal allergic rhinitis in patients 5 years and older and for the symptomatic treatment of vasomotor rhinitis in patients 12 years and older. Ophthalmic azelastine solution is indicated for the treatment of itchy eyes associated with allergic conjunctivitis.
...

Associated Conditions
Allergic Conjunctivitis (AC), Allergic Rhinitis (AR), Allergy to Tree Pollen, Atopy Keratoconjunctivitis, Blepharitis allergic, Perennial Allergic Rhinitis (PAR), Seasonal Allergic Rhinitis, Vasomotor Rhinitis, Allergic eye disorders
Associated Therapies
-
health.com
·

FDA Plans to Ban Ineffective Cold Medicine Ingredient—How It Will Affect You

FDA proposes to ban oral phenylephrine from OTC drugs due to ineffectiveness in treating nasal congestion, despite its common use in cold medications. Public comment period open until May 7, 2025, with no safety concerns cited. Proposal does not affect nasal spray form. Alternatives include nasal sprays, oral pseudoephedrine, and antihistamine nasal sprays.
© Copyright 2024. All Rights Reserved by MedPath